BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30622476)

  • 1. Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach.
    Florian A; Patrascu A; Tremmel R; Rösch S; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    Front Physiol; 2018; 9():1770. PubMed ID: 30622476
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach.
    Becker S; Florian A; Patrascu A; Rösch S; Waltenberger J; Sechtem U; Schwab M; Schaeffeler E; Yilmaz A
    J Cardiovasc Magn Reson; 2016 May; 18(1):25. PubMed ID: 27150296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac involvement in female Duchenne and Becker muscular dystrophy carriers in comparison to their first-degree male relatives: a comparative cardiovascular magnetic resonance study.
    Florian A; Rösch S; Bietenbeck M; Engelen M; Stypmann J; Waltenberger J; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2016 Mar; 17(3):326-33. PubMed ID: 26113120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial fibrosis imaging based on T1-mapping and extracellular volume fraction (ECV) measurement in muscular dystrophy patients: diagnostic value compared with conventional late gadolinium enhancement (LGE) imaging.
    Florian A; Ludwig A; Rösch S; Yildiz H; Sechtem U; Yilmaz A
    Eur Heart J Cardiovasc Imaging; 2014 Sep; 15(9):1004-12. PubMed ID: 24686257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum MyomiRs as Biomarkers for Female Carriers of Duchenne/Becker Muscular Dystrophy.
    Zhang J; Meng Q; Zhong J; Zhang M; Qin X; Ni X; Ma J; He Y; Zeng D; Lan D
    Front Neurol; 2020; 11():563609. PubMed ID: 33071947
    [No Abstract]   [Full Text] [Related]  

  • 6. Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing.
    Mah ML; Cripe L; Slawinski MK; Al-Zaidy SA; Camino E; Lehman KJ; Jackson JL; Iammarino M; Miller N; Mendell JR; Hor KN
    Int J Cardiol; 2020 Oct; 316():257-265. PubMed ID: 32473283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as biomarkers for myocardial fibrosis in patients with left ventricular non-compaction cardiomyopathy.
    Szemraj-Rogucka ZM; Szemraj J; Masiarek K; Majos A
    Arch Med Sci; 2019 Mar; 15(2):376-384. PubMed ID: 30899290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging.
    Lang SM; Shugh S; Mazur W; Sticka JJ; Rattan MS; Jefferies JL; Taylor MD
    Pediatr Cardiol; 2015 Oct; 36(7):1495-501. PubMed ID: 25976773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating MicroRNAs in Duchenne Muscular Dystrophy.
    Mousa NO; Abdellatif A; Fahmy N; Zada S; El-Fawal H; Osman A
    Clin Neurol Neurosurg; 2020 Feb; 189():105634. PubMed ID: 31838454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel free-circulating and extracellular vesicle-derived miRNAs dysregulated in Duchenne muscular dystrophy.
    Catapano F; Scaglioni D; Maresh K; Ala P; Domingos J; Selby V; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Voit T; Verschuuren JJGM; Niks EH; Straub V; Morgan J; Muntoni F
    Epigenomics; 2020 Nov; 12(21):1899-1915. PubMed ID: 33215544
    [No Abstract]   [Full Text] [Related]  

  • 11. Myocardial late gadolinium enhancement is associated with clinical presentation in Duchenne muscular dystrophy carriers.
    Wexberg P; Avanzini M; Mascherbauer J; Pfaffenberger S; Freudenthaler B; Bittner R; Bernert G; Weidinger F
    J Cardiovasc Magn Reson; 2016 Sep; 18(1):61. PubMed ID: 27660108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies.
    García-Giménez JL; García-Trevijano ER; Avilés-Alía AI; Ibañez-Cabellos JS; Bovea-Marco M; Bas T; Pallardó FV; Viña JR; Zaragozá R
    Orphanet J Rare Dis; 2022 Dec; 17(1):450. PubMed ID: 36575500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.
    Roncarati R; Viviani Anselmi C; Losi MA; Papa L; Cavarretta E; Da Costa Martins P; Contaldi C; Saccani Jotti G; Franzone A; Galastri L; Latronico MV; Imbriaco M; Esposito G; De Windt L; Betocchi S; Condorelli G
    J Am Coll Cardiol; 2014 Mar; 63(9):920-7. PubMed ID: 24161319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary myocardial dysfunction in autosomal dominant EDMD. A tissue doppler and cardiovascular magnetic resonance study.
    Smith GC; Kinali M; Prasad SK; Bonne G; Muntoni F; Pennell DJ; Nihoyannopoulos P
    J Cardiovasc Magn Reson; 2006; 8(5):723-30. PubMed ID: 16891232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic utility of cardiac magnetic resonance for detection of cardiac involvement in female carriers of Duchenne muscular dystrophy.
    Iwase T; Takao S; Akaike M; Adachi K; Sumitomo-Ueda Y; Yagi S; Niki T; Kusunose K; Tomita N; Hirata Y; Yamaguchi K; Koshiba K; Taketani Y; Yamada H; Soeki T; Wakatsuki T; Aihara K; Harada M; Nishitani H; Sata M
    Heart Asia; 2010; 2(1):52-5. PubMed ID: 27325943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of miRNA-29, -23 and -21 in urine of Duchenne muscular dystrophy patients.
    Catapano F; Domingos J; Perry M; Ricotti V; Phillips L; Servais L; Seferian A; Groot I; Krom YD; Niks EH; Verschuuren JJ; Straub V; Voit T; Morgan J; Muntoni F
    Epigenomics; 2018 Jul; 10(7):875-889. PubMed ID: 29564913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy.
    Fang L; Ellims AH; Moore XL; White DA; Taylor AJ; Chin-Dusting J; Dart AM
    J Transl Med; 2015 Sep; 13():314. PubMed ID: 26404540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
    Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
    Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miR-206 and other muscle-specific microRNAs as non-invasive biomarkers for Duchenne muscular dystrophy.
    Hu J; Kong M; Ye Y; Hong S; Cheng L; Jiang L
    J Neurochem; 2014 Jun; 129(5):877-83. PubMed ID: 24460924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional 4D Cardiac Magnetic Resonance Strain Predicts Cardiomyopathy Progression in Duchenne Muscular Dystrophy.
    Earl CC; Jauregui AM; Lin G; Hor KN; Markham LW; Soslow JH; Goergen CJ
    medRxiv; 2023 Nov; ():. PubMed ID: 37986975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.